Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free GANX Stock Alerts

Gain Therapeutics (GANX) Earnings Date, Estimates & Call Transcripts

Gain Therapeutics logo
$1.80 -0.03 (-1.37%)
As of 02:08 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Gain Therapeutics Earnings Summary

Gain Therapeutics posted Q1 2026 earnings on May 11, 2026, reporting an EPS of -$0.13, which hit the consensus estimate of -$0.13. With a trailing EPS of -$0.58, Gain Therapeutics' earnings are expected to decrease next year, from ($0.54) to ($0.60) per share.

Upcoming Q2
Earnings Date
Aug. 11Before Market OpensEstimated
Consensus EPS
(May. 11)
-$0.13
Actual EPS
(May. 11)
-$0.13

Q1 2026 Earnings Resources

GANX Upcoming Earnings

Gain Therapeutics' next earnings date is estimated for Tuesday, August 11, 2026, based on past reporting schedules.

Powered by Quartr
Get Gain Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Gain Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

GANX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Gain Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.13-$0.13-$0.13
Q2 20262-$0.13-$0.13-$0.13
Q3 20262-$0.16-$0.13-$0.15
Q4 20262-$0.20-$0.11-$0.16
FY 2026 8 -$0.62 -$0.50 -$0.56
Q1 20271-$0.12-$0.12-$0.12
Q2 20271-$0.12-$0.12-$0.12
Q3 20271-$0.13-$0.13-$0.13
Q4 20271-$0.11-$0.11-$0.11

Gain Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2026
(Estimated)		--------
5/11/2026Q1 2026-$0.13-$0.13--$0.13$0.03M-
3/26/2026Q4 2025-$0.14-$0.11+$0.03-$0.11$0.03M-
11/12/2025Q3 2025-$0.15-$0.15--$0.15--
8/12/2025Q2 2025-$0.17-$0.19 -$0.02-$0.19--
5/14/2025Q1 2025-$0.16-$0.16--$0.16$0.03M-
3/27/2025Q4 2024-$0.18-$0.11+$0.07-$0.11--
8/8/2024--$0.31-$0.42 -$0.11-$0.42--

Data powered by Fiscal.ai.

Gain Therapeutics Earnings - Frequently Asked Questions

Gain Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 11th, 2026 based off last year's report dates. Learn more on GANX's earnings history.

In the previous quarter, Gain Therapeutics (NASDAQ:GANX) reported ($0.13) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.13). Learn more on analysts' earnings estimate vs. GANX's actual earnings.

Gain Therapeutics (NASDAQ:GANX) has a recorded net income of -$20.16 million. GANX has generated -$0.58 earnings per share over the last four quarters.

Gain Therapeutics' earnings are expected to decrease from ($0.54) per share to ($0.60) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:GANX) was last updated on 5/27/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel